CD44 and myeloid sarcoma: Variant isoforms of CD44 may further refine this process: for example, splice variants like CD44v7–v8 are linked to active lesions in multiple sclerosis (MS) patients, suggesting they enhance targeted adhesion, retention, or specific ligand interactions in inflamed CNS areas, involving several immune cells [4].